DDO001F
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $20,388 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $20,388 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A 52 WEEK RANDOMIZED, SINGLE-MASKED, MULTICENTER PROOF OF CONCEPT STUDY OF BINOCULAR VIDEOGAMES VERSUS PATCHING FOR AMBLYOPIA IN CHILDREN 4-7 YEARS OF AGE WITH AN OPEN-LABEL SUBSTUDY OF BINOCULAR VIDEOGAMES IN CHILDREN 8-12 YEARS OF AGE | Novartis Pharmaceuticals Corporation | $20,388 | 0 |
Top Doctors Receiving Payments for DDO001F
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Los Angeles, CA | $20,388 | 2 |
Manufacturing Companies
Product Information
- Type Product
- Total Payments $20,388
- Total Doctors 0
- Transactions 2
About DDO001F
DDO001F is a product associated with $20,388 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharmaceuticals Corporation.
Payment data is available from 2021 to 2021. In 2021, $20,388 was paid across 2 transactions to 0 doctors.
The most common payment nature for DDO001F is "Unspecified" ($20,388, 100.0% of total).
DDO001F is associated with 1 research study, including "A 52 WEEK RANDOMIZED, SINGLE-MASKED, MULTICENTER PROOF OF CONCEPT STUDY OF BINOCULAR VIDEOGAMES VERSUS PATCHING FOR AMBLYOPIA IN CHILDREN 4-7 YEARS OF AGE WITH AN OPEN-LABEL SUBSTUDY OF BINOCULAR VIDEOGAMES IN CHILDREN 8-12 YEARS OF AGE" ($20,388).